Our findings were consistent with those of other studies showing that the expression levels of Nrf2, and its downstream targets HO-1 and NQO1 were significantly decreased in the untreated DKD group compared with the nondiabetic control group. Here, NFE2L2 is linked to diabetic kidney disease.